Publikationen

Hier finden Sie einen Überblick über die Autoren, sowie die Titel mit Quellenangaben seit 1983 bis 2019. Einige der Dissertationen sind noch in Arbeit.

Autoren Titel Quelle
(Buch, Zeitschriten, Seiten)
Jahr
176 Filser M, Baetge SJ, Balloff C, Buchner A, Fink GR, Heibel M, Meier U, Rau D, Renner A, Schreiber H, Ulrich S, Penner IK   Mental symptoms in MS (MeSyMS): development and validation of a new assessment. Multiple Sclerosis and Related Disorders (MSARD). DOI: 10.1016/j.msard.2021.102744 2021
175 Filser M, Baetge SJ, Balloff C, Buchner A, Fink GR, Heibel M, Meier U, Rau D, Renner A, Schreiber H, Ulrich S, Penner IK   Neue Optionen in der Schlaganfalltherapie Heilberufe, Pflege Praxis,  09/2020  2020
174 Filser M, Baetge SJ, Balloff C, Buchner A, Fink GR, Heibel M, Meier U, Rau D, Renner A, Schreiber H, Ulrich S, Penner IK   Effiziente Wege zu Oprtimierung vorhandener Ressourcen in der Facharztpraxis  LEHRE & PRAXIS Heft 8, 6. Jahrgang, 8/2020, ISSN 2199-3564 2020
173 Filser M, Baetge SJ, Balloff C, Buchner A, Fink GR, Heibel M, Meier U, Rau D, Renner A, Schreiber H, Ulrich S, Penner IK   Gaining First Insights on Secondary Progressive Multiple Sclerosis Patients Treated With Siponi-mod in Clinical Routine: Protocol of the Noninterventional Study AMASIA.  JMIR Res Protoc 2020 | vol. 9 | iss. 7 | e19598 | p. 1-13.  2020
172 Filser M, Baetge SJ, Balloff C, Buchner A, Fink GR, Heibel M, Meier U, Rau D, Renner A, Schreiber H, Ulrich S, Penner IK   Einsatz von Cannabis bei chronischen neuropathischen Schmerzen. Ein kritisches Review zur Evidenz der aktuellen Verschreibungssituation. Schmerzmedizin 2020; 36 (5): 54-62. 2020
171 Penner IK & Schreiber H. Kognition und Multiple Sklerose: Hintergründe, Diagnostik und Therapie. DGNeurologie - Zeitschrift der Deutschen Gesellschaft für Neurologie. ISSN 2524-3446. DGNeurologie DOI 10.1007/s42451-019-00132-1 2019
170 Flachenecker P, Ammerbach A, Baum K, Knop KC, Petereit HF,       Schreiber H  Empfehlungen zur Progressionsbeurteilung bei primär progredienter Multipler Sklerose (PPMS) in der klinischen Praxis.  Thieme Praxis Report 2019; 11: 1–16. 2019
169 Ziemssen T, Lang M, Tackenberg B, Schmidt S, Albrecht H, Klotz L, Haas J, Lassek C, Couto CA, Findlay JA, Cornelissen C; PANGAEA study group. Real-world persistence and benefit–risk profile of fingolimod over 36 months in Germany Neurol Neuroimmunol Neuroinflamm. 2019 Mar 7;6(3):e548. doi: 10.1212/NXI.0000000000000548. eCollection 2019 May. 2019
168 Tjalf Ziemssen*, Michael Lang, Björn Tackenberg, Stephan Schmidt, Holger Albrecht, Luisa Klotz, Judith Haas, Christoph Lassek, Christian Cornelissen, Benjamin Ettle;  on behalf of the PANGAEA Study Group Long-term real-world evidence for sustained clinical benefits of fingolimod following switch from natalizumab Mult Scler Relat Disord. 2019 Dec 13;39:101893. doi: 10.1016/j.msard.2019.101893 2019
167 Michael Lang*, Stefan Ringbauer, Martin Mayr and Lukas Cepek How to improve disease management of chronically ill patients? Perception of telemetric ECG recording and a novel software application Clin Res Trials, Volume 5: 1-6, 2019 doi: 10.15761/CRT.1000266 2019
166 Michael Lang, Martin Mayr, Stefan Ringbauer,  Lukas Cepek PatientConcept App: Key Characteristics, Implementation, and its Potential Benefit Neurol Ther; https://doi.org/10.1007/s40120-019-0133-4 2019
165 Kolb-Mäurer A, Sunderkötter C, Kukowski B, Meuth S, Beissert S, Nelles G, Schreiber H, Leutmezer F, Menge T, Lassek C, Freidel M, Stirnweiß T An update on Peginterferon beta-1a Management in Multiple Sclerosis: Results from an interdisciplinary Board of German and Austrian Neurologists and Dermatologists. BMC Neurology 19 (130). 2019
164 Vill K, Müller‑Felber W, Gläser D, Kuhn M, Teusch V, Schreiber H, Weis J, Klepper J, Schirmacher A, Blaschek A, Wiessner M, Strom TM, Dräger B, Hofmeister K, Kiltz K, Tacke M, Gerstl L, Young P, Horvath R, Senderek J.  SACS variants are a relevant cause of autosomal recessive hereditary motor and sensory neuropathy.  Human Genetics (2018) 137:911–919. https://doi.org/10.1007/s00439-018-1952-6  2018
163 Baumann M, Schreiber H, Schlotter-Weigel B, Löscher WN, Stucka R, Karall D, Strom TM, Bauer P, Krabichler B, Fauth C, Glaeser D, Senderek J.  MPV17 mutations in juvenile- and adult-onset axonal sensorimotor polyneuropathy. Clin Genet. 2018;1–5. https://doi.org/10.1111/cge.13462. 2018
162 David OJ, Berwick A, Pezous N, Lang M, Tiel-Wilck K, Ziemssen T, Li P, Hara H, Schmouder R. Determination of Seminal Concentration of Fingolimod and Fingolimod-Phosphate in Multiple Sclerosis Patients Receiving Chronic Treatment With Fingolimod. Clin Pharmacol Drug Dev. 2018 Feb;7(2):217-221. doi: 10.1002/cpdd.424. Epub 2017 Dec 19. 2018
161 Ziemssen T, Lang M, Tackenberg B, Schmidt S, Albrecht H, Klotz L, Haas J, Lassek C, Medin J, Cornelissen C; PANGAEA study group. Clinical and Demographic Profile of Patients Receiving Fingolimod in Clinical Practice in Germany and the Benefit-Risk Profile of Fingolimod After 1 Year of Treatment: Initial Results From the Observational, Noninterventional Study PANGAEA. Neurotherapeutics. 2018 Jan;15(1):190-199. doi: 10.1007/s13311-017-0595-y. 2018
160 Pfeuffer S, Schmidt R, Straeten FA, Pul R, Kleinschnitz C, Wieshuber M, Lee DH, Linker RA, Doerck S, Straeten V, Windhagen S, Pawlitzki M, Aufenberg C, Lang M, Eienbroeker C, Tackenberg B, Limmroth V, Wildemann B, Haas J, Klotz L, Wiendl H, Ruck T, Meuth SG. Efficacy and safety of alemtuzumab versus fingolimod in RRMS after natalizumab cessation. J Neurol. 2018 Nov 16. doi: 10.1007/s00415-018-9117-z. / J Neurol. 2019 Jan;266(1):165-173. doi: 10.1007/s00415-018-9117-z. Epub 2018 Nov 16. 2018
159 Kleiter I, Lang M, Jeske J, Norenberg C, Stollfuss B, Schurks M.  Adherence, satisfaction and functional health status among patients with multiple sclerosis using the BETACONNECT(R) autoinjector: a prospective observational cohort study. BMC Neurol. 2017;17(1):174 2017
158 M. Filser, H. Schreiber, M. Lang, J. Pöttgen, S. Ullrich, I.K. Penner The Brief International Cognitive Assessment in Multiple Sclerosis (BICAMS): Results from the German validation study Journal of Neurology / https://doi.org/10.1007/s00415-018-9034-1 J Neurol. 2018 Nov;265(11):2587-2593. 2017
157 A. Schmitt, B. Rall, I. Haase, J. Durner, H. Schreiber (2017).   Vergleich eines Roboter-gestützten Gangtrainings mit konventionellem Gangtraining bei Patienten mit fortgeschrittenem idiopathischen Parkinson-Syndrom.  Neurol Rehabil 2017; 23(3): 237-246. 2017
156 Trenkwalder C1, Canelo M2, Lang M3, Schroeder H4, Kelling D4, Berkels R4, Schollmayer E4, Heidbrede T4, Benes H5. Management of augmentation of restless legs syndrome with rotigotine: a 1-year observational study. Sleep Med. 2017 Feb;30:257-265. doi: 10.1016/j.sleep.2015.10.006. Epub 2015 Nov 11. 2017
155 Limmroth V1, Ziemssen T2, Lang M3, Richter S4, Wagner B4, Haas J5, Schmidt S6, Gerbershagen K1, Lassek C7, Klotz L8, Hoffmann O9, Albert C9, Schuh K10, Baier-Ebert M10, Wendt G10, Schieb H10, Hoyer S10, Dechend R11, Haverkamp W12. Electrocardiographic assessments and cardiac events after fingolimod first dose - a comprehensive monitoring study BMC Neurol. 2017 Jan 18;17(1):11. doi: 10.1186/s12883-016-0789-7. 2017
154 Ziemssen T, Lang M, Tackenberg B, Schmidt S, Albrecht H, Klotz L, Haas J, Lassek C, Medin J, Cornelissen C; PANGAEA study group. Clinical and Demographic Profile of Patients Receiving Fingolimod in Clinical Practice in Germany and the Benefit-Risk Profile of Fingolimod after 1 Year of Treatment: Initial Results from the Observational, Non-Interventional Study PANGAEA Neurotherapeutics. 2017 Dec 22. doi: 10.1007/s13311-017-0595-y. [Epub ahead of print] 2017
153 David OJ1, Berwick A2, Pezous N1, Lang M3, Tiel-Wilck K4, Ziemssen T5, Li P6, Hara H1, Schmouder R7. Determination of seminal concentration of fingolimod and fingolimod-phosphate in multiple sclerosis patients receiving chronic treatment with fingolimod Clin Pharmacol Drug Dev. 2017 Dec 19. doi: 10.1002/cpdd.424. [Epub ahead of print] 2017
152 Gereon Nelles, Michael Lang Teleneurologie – Chancen und Risiken Forum neurologicum der Deutschen Gesellschaft für Neurologie; Thieme 2017 ; Akt Neurol 2017; 44: 126–143 2017
151 Ingo Kleiter1, Michael Lang2, Judith Jeske3, Christiane Norenberg4, Barbara Stollfuß5, Markus Schürks6 BETAEVAL- Adherence and satisfaction with the BETACONNECT BMC Neurol. 2017; 17: 174.(Published online 2017 Sep 6. doi:  10.1186/s12883-017-0953-8) 2017
150 Klotz L, Berthele A, Brück W, Chan A, Flachenecker P, Gold R, Haghikia A, Hellwig K, Hemmer B, Hohlfeld R, Korn T, Kümpfel T, Lang M, Limmroth V, Linker RA, Meier U, Meuth SG, Paul F, Salmen A, Stangel M, Tackenberg B, Tumani H, Warnke C, Weber MS, Ziemssen T, Zipp F, Wiendl H. Monitoring of blood parameters under course-modified MS therapy : Substance-specific relevance and current recommendations for action Nervenarzt. 2016 Jun;87(6):645-59. doi: 10.1007/s00115-016-0077-1. Review. German. 2016
149 U. K. Zettl, H. Schreiber, U. Bauer-Steinhusen, T. Glaser, K. Hechenbichler, M. Hecker; for the BETAPATH Study Group   Baseline predictors of persistence to first disease-modifying treatment in multiple sclerosis Acta Neurol Scand 2016; 1–6 2016
148 Adam Strzelczyk, Arnfin Bergmann, Valeria Biermann, Stefan Braune, Lienhard Dieterle, Bernhard Forth, Lena-Marie Kortland, Michael Lang, Thomas Peckmann, Oliver Schöffski, Karl-Otto Sigel, Felix Rosenowa Neurologist adherence to clinical practice guidelines and costs in patients with newly diagnosed and chronic epilepsy in Germany Epilepsy & Behavior 64 (2016) 75–82 2016
147 Klotz L., Berthele A., Brück W., Chan A., Flachenecker P., Gold R., Haghikia A., Hellwig K., Hemmer B., Hohlfeld R., Korn T., Kümpfel T., Lang M., Limmroth V., Linker RA., Meier U., Meuth SG., Paul F., Salmen A., Stangel M., Tackenberg B., Tumani H., Warnke C., Weber MS., Ziemssen T., Zipp F., Wiendl H. Monitoring of blood parameters under course-modified MS therapy : Substance-specific relevance and current recommendations for action Nervenarzt. 2016 Jun; 87(6): 645-59. doi: 10.1007/s00115-016-0077-1. 2016
146 Braune S., Lang M., Bergmann A., NeuroTransData Study Group. Efficacy of fingolimod is superior to injectable disease modifying therapies in second-line therapy of relapsing remitting multiple sclerosis. J Neurol. 2016 Feb;263(2): 327-33. doi: 10.1007/s00415-015-7970-6. Epub 2015 Dec 8. 2016
145 Schreiber H., Lang M., Kiltz K., Lang C. Is personality profile a relevant determinant of fatigue in multiple sclerosis. Front. Neurol- Vol. 6; 2; 1-7. doi: 10.3389/fneur.2015.00002. 2015
144 Trenkwalder C., Canelo M., Lang M., Schroeder H., Kelling D., Berkels R., Schollmayer E., Heidbrede T., Benes H. Management of augmentation of restless legs syndrome with rotigotine: a 1-year observational study. Sleep Med. 2015 Nov 11. pii: S1389-9457(15)02018-3. doi: 10.1016/j.sleep.2015.10.006. [Epub ahead of print]. 2015
143 Ziemssen T., Albrecht H., Haas J., Klotz L., Lang M., Lassek C., Schmidt S., Tackenberg B., Cornelissen C. 36 Months Pangaea: A 5-Year Non-Interventional Study of Safety, Efficacy and Pharmacoeconomic Data for Fingolimod Patients In Daily Clinical Practice. Value Health. 2015 Nov;18(7): A749. doi: 10.1016/j.jval.2015.09.2894. Epub 2015 Oct 20. 2015
142 Ziemssen T., Rauer S., Stadelmann C., Henze T., Koehler J., Penner IK., Lang M., Poehlau D., Baier-Ebert M., Schieb H., Meuth S. Evaluation of Study and Patient Characteristics of Clinical Studies in Primary Progressive Multiple Sclerosis: A Systematic Review. PLoS One. 2015 Sep 22; 10(9): e0138243. doi: 10.1371/journal.pone.0138243. eCollection 2015. 2015
141 Kolber P., Luessi F., Meuth SG., Klotz L., Korn T., Trebst C., Tackenberg B., Kieseier B. Kümpfel T., Fleischer V., Tumani H., Wildemann B., Lang M., Flachenecker P., Meier U., Brück W., Limmroth V., Haghikia A., Hartung HP., Stangel M., Hohlfeld R., Hemmer B., Gold R., Wiendl H., Zipp F. Current aspects of therapy conversion for multiple sclerosis. Nervenarzt. 2015 Oct; 86(10): 1236-47. doi: 10.1007/s00115-015-4368-8. 2015
140 Rau D., Lang M., Harth A., Naumann M., Weber F., Tumani H., Bayas A. Listeria Meningitis Complicating Alemtuzumab Treatment in Multiple Sclerosis--Report of Two Cases. Int J Mol Sci. 2015 Jun 29;16(7):14669-76. doi: 10.3390/ijms160714669. 2015
139 Schreiber H., Lang M., Kiltz K., Lang C. Is personality profile a relevant determinant of fatigue in multiple sclerosis? Front Neurol. 2015 Feb 4;6:2. doi: 10.3389/fneur.2015.00002. eCollection 2015. 2015
138 Freidel M., Tiel-Wilck K., Schreiber H., Prechtl A., Essner U., Lang M. Drug-resistant MS spasticity treatment with Sativex(®) add-on and driving ability. Acta Neurol Scand. 2015 Jan; 131(1) :9-16. doi: 10.1111/ane.12287. Epub 2014 Sep 11. 2015
137 Baum K., Boldt HJ., Chan A., Harms L., Hartung HP., Kieseier BC., Korn T., Mäurer M., Meier U., Schreiber H., Tackenburg B., Wiendl H., Hziemssen T., Gold R. Dimethylfumarat in der Therapie der schubförmigen MS. Verträglichkeit und Management von Nebenwirkungen. Nervenheilkunde 33: 175-179. 2014
136 Freidel M., Tiel-Wilck K., Schreiber H., Prechtl A., Essner U., Lang M. Drugresistant MS spasticity treatment with Sativex add-on and driving ability. Acta Neurol Scand: DOI: 10.1111/ane. 12287. 2014
135 Walter MC., Reilich P., Thiele S., Schessl J., Schreiber H., Reiners K., Kress W., Müller-Reible C., Vorgerd M., Urban P., Schrank B., Deschauer M., Schlotter-Weigel B., Kohnen R., Lochmüller H. Treatment of diysferlinopathy with deflacort. A double-blind, placebo-controlled clinical trial. Orphanet J of Rare Dis 8(1): 26ff. 2013
134 Sarkozy A., Hicks D., Hudson J., Laval SH., Barresi R., Hilton-Jones D., Dreschauer M., Harris E., Rufibach L., Hwang E., Bashir R., Walter MC., Krause S., van den Bergh P., Illa I., Pénisson-Besnier H., De Waele L., Runbull D., Guglieri M., Schrank B., Schoser B., Seeger J., Schreiber H., Gläster D., Ray P., Schapira AH, Swingler R., Turner C., Wagner KR., Maddison P., Shaw PJ., Straub V., Bushby K., Lochmüller M. ANO5 gene analysis in a large cohort of patients with anoctaminopathy: confirmation of male prevalence and high occurrence of the common exon 5 gene mutation. Human Mutat 34: 1111-1118. 2013
133 Boeru G., Milanov I., De Robertis F., Kozubski W., Lang M., Rojas-Ferrares S., Tomlinson M. ExtaviJect® 30G device for subcutaneous self-injection of interferon beta-1b for multiple sclerosis: a prospective European study. Med Devices (Auckl). 2013 Nov 15; 6: 175-84. doi: 10.2147/MDER.S52590. eCollection 2013. 2013
132 Braune S., Lang M., Bergmann A., NTD Study Group. Second line use of Fingolimod is as effective as Natalizumab in a German out-patient RRMS-cohort. J Neurol. 2013 (12): 2981-5. doi: 10.1007/s00415-013-7082-0. Epub 2013. 2013
131 Korinna Karampampa1,2, Anders Gustavsson1*,3, Carolin Miltenburger4*, Katja Neidhardt5 and Michael Lang6 Treatment experience, burden and
unmet needs (TRIBUNE) in MS study: results from Germany
Multiple Sclerosis Journal
18(6) (Suppl 2): 23–27
2012
130 Sarkozy A., Deschauer M., Carlier RY., Schrank B., Seeger J., Wakter MC., Schoser B., Reilich P., Leturq F., Radunovic A., Laforet P., Eymard B., Schreiber H., Hicks D., Vaidya SS., Gläser D., Carlier PG., Bushby K., Lochmüller H., Straub V. Muscle MRI findings in limb girdle muscular dystrophy typ 2L. Neuromusc Disorders 22: Suppl. 2: S122-129. 2012
129 Bischoff C., Schreiber H., Bergmann A. Background information on multiple sclerosis patients stopping ongoing immunmodulatory therapy: a multi-center study in a community-based inviorment. J Neurol 259: 2347-2353. 2012
128 Schreiber H., Kiltz K., Lang M., Flachenecker P., Meissner H., Freidel M., Herbst H., Scholz E., Hofmann W., Schlegel E., Elias W., Gehring K., Eckhardt U., Bergmann A., Reifschneider G., Ries S., Rupp E., Ring C. Fatigue, Kognition und Persönlichkeit bei Patienten mit schubförmiger MS (RRMS). Der Nervenarzt 81: 39-40. 2010
127 Devonshire V., Arbizu T., Borre B., Lang M., Lugaresi A., Singer B., Verdun di Cantogno E., Cornelisse P. Patient-rated suitability of a novel electronic device for self-injection of subcutaneous interferon beta-1a in relapsing multiple sclerosis: an international, single-arm, multicentre, Phase IIIb study. BMC Neurol. 2010; 10:28. doi: 10.1186/1471-2377-10-28. 2010
126 Cepok S., Schreiber H., Hoffmann S., Zhou D., Neuhas O., von Geldern G., Hochgesand S., Nessler S., Rothenhammer V., Lang M., Hartung HP., Hemmer B. Enhancement of chemokine expression by interferon beta therapy in patiens with multiple sclerosis. Arch Neurol 66: 1-8. 2009
125 Soukup GR., Sperfeld AD., Uttner., I., Karitzky J., Ludolph AC., Kassubek J., Schreiber H. Fronto-temporale cognitive function in X-linked spinal and bulbar muscular atrophy (SBMA): a controlled study in 20 patients. J Neurol, 256: 1869-1875. 2009
124 Sperfeld AD., Müller HP., Unrath A., Jüngling F., Uttner I., Schreiber H., Ludolph AC., Kassubek J. Die zentralnervöse Begleitung der spino-bulbären Muskelatrophie Typ Kennedy: ganzhirnbasierte, multiparametische MRT-Untersuchungen und neuropsychologische Befunde. Akt Neurologie DOI: 10.1055/s-0029-1338905. 2009
123 Riesner H., Zeitler C., Schreiber H., Wild A. Eine additive Therapie chronischer Schmerzen bei fortgeschrittener Gon/Coxathrose mit dem selektiven Serotonin-Reuptake-Hemmer Fluvoxamin (Fevarin). Z Orthop Unfall 146: 742-746. 2008
122 Pinkhardt EH., Jürgens R., Graf M., Ecker D., Born J., Becker W., Ludoplph AC., Schreiber H. Signs of impaired selective attention in patients with amyotrophic lateral sclerosis (ALS). J Neurol 255: 532-538. 2008
121 Bengel D., Susa M., Schreiber H., Ludolph AC., Tumani H. Early diagnosis of rhinocerebral mucormycosis by cerebrospinal fluid analysis and determination of 16s rRNA gene sequence.  Eur J Neurol 14(9): 1067-1070. 2007
120 Deschauer M., Morgenroth A., Joshi PR., Gläser D., Chinnery PP., Aasly J., Schreiber H., Knape M., Zierz S., Vorgerd M. Analysis of spectrum and frequencies of mutations in Mc Ardle diesease. J Neurol 254(6): 797-802. DOI: 10.1007/S004-006-0447-x (online) . 2007
119 Uttner I., Mottaghy FM., Schreiber H., Riecker A., Ludolph AC., Kassubek J. Primary progressive aphasia accompanied by environmental sound agnosia: a neurophsychological, MRI and PET study.  Psychiatry Research: Neuroimaging 146: 191.197. 2006
118 Jurkat-Rott K., Schreiber H., Goebel HH., Lehmann-Horn F. Progressive Muskeldystrophien, Myotonien, periodische Paralysen, distale und kongenitale Myopathien. In Wallesch CW (Hrsg.) Neurologie. Diagnostik und Therapie in Klinik und Praxis. 1. Auflage. Kapitel 57, 797-817. Elsevier. Urban & Fischer. 2005
117 Schreiber H., Gaigalat T., Wiedemuth-Catrinescu U., Graf M., Uttner I., Muche R., Ludoph AC. Cognitive function in bulbar- and spinal-onset ALS - a longitudinal study in 52 patients. J Neurol 252: 772-2781. 2005
116 Brummer D., Walter MC., Palmbach M., Knirsch U., Karitzky J., Tomczak R., Braun C., Grundhoff N., Bornemann A., Müller CR., Lochmüller H., Schreiber H. Long-term MRI and clinical follow-up of symptomatic and presymptomatic carriers of dysferlin gene mutations. Acta Myologica 24(1): 6-16. 2005
115 Walter MC., Petersen JA., Stucka R., Fischer D., Schröder R., Vorgerd M., Schroers A., Schreiber H., Hermann CO., Knirsch U., Rosenbohm A., Huebner A., Barisic N., Horvath R., Komoly S., Reilich P., Müller-Felber W., Pongratz D., Müler JS., Auerswald EA., Lochmüller H. FKRP (826>A) frequently causes limb-girdle muscular dystrophy in German patients. J Med Genet 41 (4): 1-7. 2004
114 Schreiber H. Les dysferlinopathies. Observations longitudinales de données cliniques, paracliniques et de l´imagerie á résonance magnétique dans des familles regroupant des membres symptomatiques et présymptomatiques. Diplóme de Myologie. Univ. Pierre et Marie Curie. Sorbonne VI. CHU Pitié-Salpêtriére. Paris. 2003
113 Sperfeld AD., Karitzky J., Brummer D., Schreiber H., Häussler J., Ludolph AC., Hanemann CO. X-linked bulbospinal neuronopathy. Kennedy Disease. Arch Neurol (JAMA Neurology) 59: 1921-1926. 2003
112 Walter MC., Braun C., Vorgerd C., Poppe M., Thirion C., Schmidt C., Schreiber H., Knirsch U., Brummer D., Müller-Felber W., Pongratz D., Müller-Höcker J., Hübner A., Lochmüller H. Variable reduction of caveolin-3 in patients with LGMD2B/MM. J Neurol 250:1431-1438. 2003
111 Butz M., Wollinsky KH., Wiedemuth-Catrinescu U., Sperfeld A., Winter S., Mehrkens HH., Ludolph AC., Schreiber H. Longitudinal effects of noninvasive positive pressure ventilation in patients with amyotrophic lateral sclerosis. Am J Phys Med Rehabil 82(8): 597-604. 2003
110 Butz M., Koch MC., Müller-Felber W., Lemmers RJLF., van der Maarek SM., Schreiber H. Facioscapulohumeral muscular dystrophy - phenotype-genotype corellation in patients with borderline D4Z4 repeat numbers. J Neurol 250: 932-937. 2003
109 Schreiber H. Störungen des Bewegungsapparates. In F. Lehmann-Horn & A.C. Ludolph (Hrsg.): Neurologische Therapie. 3. Auflage. München: Urban & Schwarzenberg Verlag. Pp. 433-443. 2001
108 Schreiber H. Störungen der peripheren Nerven. In F. Lehmann-Horn & A.C. Ludolph (Hrsg.): Neurologische Therapie. 3. Auflage. Urban & Fischer Verlag. Pp. 328-352. 2001
107 Koch MC., Schreiber H. Fazioskapulohumerale Muskeldystrophie - Klinische und molekulargenetische Aspekte. In R. Dengler & P. Pongratz (Hrsg). Management of Neuromuscular Diseases. Letter Nr. 21, pp. 1-12; München: Arcis-Verlag.  2001
106 Wollinsky KH., Hülser PJ., Binkmeier H., Aulkemeyer P., Bössenecker W., Huber-Hartmann KH., Rohrbach P., Schreiber H., Weber F., Kron M., Büchele G., Mehrkens HH., Ludolph AC., Rüdel R. CSF filtration is an effective treatment of Guillain-Barre syndrome. A randomized clinical trial. Neurology 57: 774-7480. 2001
105 Busse K., Köhler J., Stegmann K., Progratz D., Koch MC., Schreiber H. An inherited 4q35 EcoRI-DNA-fragment of 35 kb in a family with a sporadic case of facio-scapulo-humeral muscular dystrophy (FSHD). Neuromusc Disord 10: 178-181. 2000
104 Jürgens R., Becker., W., Schreiber H., Fegert B., Klausmann S. Saccadic tracking in schizophrenia: Incidence of hypometria and intrusions influenced by visual background and pace of stepping ? In Becker W, Deubel H & Mergner T (eds). CurrentOculomotor Research. Phsyiological and psychological aspects. New York: Plenum Press. Pp. 447-450.  1999
103 Schreiber H., Ludolph AC. Degenerative Erkrankungen des Nervensystems. Motoneuronerkrankungen und cerebelläre Ataxien.  Therapiehandbuch. Sonderdruck. München: Urbann & Schwarzenberg Verlag. P6, 1-19. 1999
102 Kern W., Born J., Schreiber H., Fehm HL. Central nervous system effects of intranasally administered insulin during euglycemia in men. Diabetes 48: 557-563. 1999
101 Schreiber H., Baur-Seack K., Kornhuber HH., Wallner B., Friedrich JM., DeWinter IM., Born J. Brain morphology in adolescents at genetic risk for schizophrenia assessed by qualitative and quantitative magnetic resonance imaging. Schizophr Res 40: 81-86. 1999
100 Schreiber H. Neurologische Manifestationen immunologischer Erkrankungen - Die Vaskulitiden. Ärztl. Praxis Neurol Psychiat 12: 628-638. 1998
99 Schreiber H., Stolz-Born G., Kornhuber HH., Born J. Investigation of electrophysiological correlates of attention and information processing as vulnerability indicators for schizophrenia. J Psychophysiology, 12: 286-300. 1998
98 Heidegger S., Mattfeldt T., Rieber A., Wikstroem M., Kern P., Kern W., Schreiber H. Orbito-spenoidal Aspergillus infection mimicking cluster headache: a case report. Cephalalgia 17 :676-679. 1997
97 Rösche J., Maurer H., Schreiber H., Kornhuber HH. Normale somato-sensibel evozierte Potentiale beim Adie-Syndrom. Die Rolle der la-Fasern. Z EEG-EMG 28: 49-51. 1997
96 Schreiber H., Rothmeier J., Stolz-Born. G., Born J., Rothenberger A., Jürgens R., Becker W., Kornhuber HH. Visually-guided saccadic eye movements in adolescents at genetic risk for schizophrenia. Schizophr Res 25: 97-109. 1997
95 Sperfeld A., Schreiber H., Reindl I., Kleber FX., Ludolph AC. Die Ergospirometrie - eine Methode zur Detektion mitochondrialer Cytopathien. Nervenarzt 70: 155-162. 1997
94 Schreiber H., Stolz-Born G., Kornhuber HH., Born J. Event-related brain potentials and psychometric performance in adolescents at genetic risk for schizophrenia. Ogura C, Koga Y, Schimokochi M (eds). Recent advances in event-related potential research Elsevier, Amsterdam. pp. 550-557. 1996
93 Lieb K., Denz E., Hess R., Schüttler R., Kornhuber HH., Schreiber H. Preattentive information processing as measured by backward masking and texton detection tasks in adolescents at high genetic risk for schizophrenia. Schizophr Res 21: 171-182. 1996
92 Schreiber H., Stolz-Born G., Kornhuber HH., Born J. Elektrophysio-logische Korrelate selektiver Aufmerksamkeit bei Kindern und Jugendlichen mit erhöhtem Schizophrenie-Risiko. Z Kinder-Jugendpsychiat 24: 282-292. 1996
91 Kotchoubey, B.I., Grözinger, B., End, H., Kornhuber, A. and Kornhuber, H. H. Individual differences in slow brain potentials in a guessing task Archives Italiennes de Biologie, 133 (1995) pp. 99-115. 1995
90 Schreiber H., Stolz-Born G., Pietroqsky R., Kornhuber HH., Fehm HL., Born J. Improved event-related poential signs of selective attention after the cholecystokinin- analog ceruletide in healthy persons. Biol Psychiatry 37: 702-712. 1995
89 Schreiber H., Rothmeier J., Becker W., Jürgens R., Born J., Stolz-Born G., Westphal KP., Kornhuber HH Comparative assessment of saccadic eye movements. Psychomotor and cognitive performance in schizophrenics, their first-degree relatives and control subjects. Acta Psychiat Scand 91: 195-201. 1995
88 Schreiber H., Kornhuber HH. Biologische Marker in der Psychiatrie: Forschungskonzept und bisherige Ergebnisse am Beispiel der Schizophrenie.  In: Lieb, K; Riemann, D; Berger, M (Hrsg.). Biologisch-psychiatrische Forschung. Stuttgart: Gustav Fischer Verlag. 196-218. 1995
87 Wollinsky KH., Minde A., Schreiber H., Kluger P., Mehrkens HH  Effektivität der Heimbeatmung bei Kleinkindern und Säuglingen. Med Klein 90: 57-59. 1995
86 Westarp ME., Schreiber H., Westarp MP., Westphal KP., Mauch E., Kornhuber HH. Cerebral magnetic resonance imaging pathology and cerebrospinal fluid proteins in sporadic amyotrophic lateral sclerosis. Clin Neuropathol 4: 228-232. 1995
85 Kornhuber AW., Lang W., Becker M., Uhl F., Goldenberg G., Lang M. Unimanual motor learning impaired by frontomedial and insular lesions in man. J Neurol. 1995 Sep; 242(9): 568-78 1995
84 Kornhuber, A.W., Bischof, W. and Kriebel, J. Frequent problems of neurologic and psychiatric assessment of flying personnel. In J. Draeger and R. Schwartz (Eds.), 41st International Congress of Aviation and Space Medicine, Monduzzi Editore, Bologna, 1994, pp. 135-138. 1994
83 Oberbeck, K.D., Kornhuber, A.W. and Kriebel, J. Examination of the visual system with steady-state visual evoked potentials - two subsystems In J. Draeger and R. Schwartz (Eds.), 41st International Congress of Aviation and Space Medicine, Monduzzi Editore, Bologna, 1994, pp. 143-147. 1994
82 Kriebel, J. and Kornhuber, A.W. Berblinger, 1770-1829, constructor of artificial limbs, advocate of the principle "heavier than air", flight pioneer, and -founder of aviation medicine? In J. Draeger and R. Schwartz (Eds.), 41st International Congress of Aviation and Space Medicine, Monduzzi Editore, Bologna, 1994, pp. 255-260. 1994
81 Mauch, E., Mayer, G., Kornhuber, A., Krapf, H., Jürgens, R., Hufnagl, J.M. and Kornhuber, H.H. Die Bedeutung der quantitativen Computertomographie für die Langzeitprognose von ischämischen Großhirninsulten Die Rehabilitation, 33 (1994) pp. 212-220. 1994
80 Kotchoubey, B.I., End, H., Grözinger, B., Kornhuber, A., Jordan, J.S. and Kornhuber, H.H. Pre- and post-movement potentials in an informed guessing situation Journal of Psychophysiology, 8 (1994) pp. 142-156. 1994
79 Kornhuber, A.W. Wehrmedizinische nervenärztliche Erfahrungen aus der deutschen Beteiligung am UN-Blauhelmeinsatz in Somalia (UNOSOM II) - 2. Teil Wehrmedizinische Monatsschrift, 38 (1994) pp. 365-368. 1994
78 Marshall L., Mölle M., Schreiber H., Fehm HL., Born J. Scalp recorded direct current potential shifts associated with the transition to sleep in man. Electroencephalogr Clin Neurophysiol 91: 346-352. 1994
77 Krause, H.R., Kornhuber, A. and Dempf, R. A technique for diagnosing the individual patterns of innervation of the trapezius muscle prior to neck dissection Journal of Craniomaxillofacial Surgery, 21(3) (1993) pp. 102-106. 1993
76 Westarp ME., Hülser PJ., Schreiber H., Westphal KP., Kolde G., Horn-Jörgensen R., Clausen Föhring B., Westarp NP., Kornhuber HH. Human retrovirus involvement in amyotrophic lateral sclerosis: A rationale for antiretroviral therapy? In: Serratrice G, Pellissiert JF, Pouget J, Blin O, Branger D, Turc F, Azulay JP (eds.). Systeme nerveux, muscles et maladies systemiques - acquistions recentes. Expasion Scientifique Francaise, Paris. Pp:250-263. 1993
75 Schreiber H., Seack K., Born J., Wallner B., Friedrich JM., Kornhuber HH. Hirnmorphologische Befunde bei Jugendlichen mit und ohne genetische Schizophrenierisiko: Eine vergleichende NMR-Studie. In: Deecke L & Lang W (Hrsg.). Kongressband des Deutsch-Österreichischen Neurologenkongresses. 1993
74 Schreiber H., Stolz-Born G., Kornhuber HH., Born J. Event-related potential correlates of selective attention in children at genetic risk for schizophrenia. In. Heinze HJ & Münte TF (eds.). New developments in event-related potentials. Boston: Birkhäuser. 319-324. 1993
73 Schreiber H., Born J., Stolz-Born G., Rothmeier J., Jürgens R., Rothenberger A., Kornhuber A., Becker W., Kornhuber HH Schizophrenie - Zentralnervöse Funktionsdefizite bei Risikokindern. TW Neurologie Psychiatri, 7: 728-737. 1993
72 Schreiber H., Kornhuber HH. Heutiger Stand der medikamentösen Therapie des Parkinson-Syndroms. Jatros Neurologie 9: 28-40. 1993
71 Westarp ME., Barmann P., Rössler J., Geiger E., Westphal KP., Schreiber H., Fuchs D., Westarp MP., Kornhuber HH Antiretroviral therapy in sporadic adult amyothrophic lateral sclerosis. NeuroReport 4: 819-822. 1993
70 Born J., Schwab B., Schwab R., Schreiber H. Acute and long-term effects of audrenocorticotropin and dexamethasone on the auditory brainstem response in multiple sclerosis patients. J Neurol 241: 75-80. 1993
69 Krapf, H., Hülser, P.-.J., Rieg, S., Kornhuber, A., Bernhart, H., Marbach-Kirchner, C. and Kornhuber, H.H. Prognostische Bedeutung ischämischer Infarktmuster im cranialen Computertomogramm für die Rehabilitation von Schlaganfallpatienten. In Mauritz K.-H. and Hömberg V. (Eds.), Neurologische Rehabilitation 2, Huber, Bern, Göttingen, 1992, pp. 136-146. 1992
68 Westphal, K.P., Grözinger, B., Reeß, J., Leibing, U., Kornhuber, A.W., Diekmann, V. and Kornhuber, H.H. Anticholinergic influences of biperidene on the EEG effects of haloperidol Clin. Physiol. Biochem., 9(1) (1992) pp. 26-34. 1992
67 Hähnel, A., Kornhuber, A., Kornhuber, H.H. and Hähnel, J. BSG-Bestimmungen bei neurovaskulären Affektionen - hilfreiche Screening-Untersuchung oder überholte Gewohnheit? Die Medizinische Welt, 43 (1992) pp. 545-550. 1992
66 Schreiber H., Stolz-Born G., heinrich H., Kornhuber HH., Born J. Attention, cognition, and motor perseveration in adolescents at genetic risk for schizophrenia and control subjects. Psychiat Res 44: 125-140. 1992
65 Schreiber H., Stolz-Born G., Kornhuber HH., Born J. Event-related potential correlates of impaired selective attention in children at high-risk for schizophrenia.  Biol Psychiatry 32:634-651. 1992
64 Westphal KP., Bauer J., Laupheimer H., Schreiber H., Westarp ME., Hülser PJ., Baumgärtner K., Wollinsky KH., van Eick H., Kornhuber HH. Verlangsamte Progression der ALS während intrathekaler Therapie mit Interferon beta. Verh Dr Ges Neurol 7: 699-700. 1992
63 Schreiber H., Stolz-Born G., Rothmeier J., Kornhuber HH., Rothenberger A., Born J. Kinder schizophrener Eltern - Neurophysiologische Hinweise auf die Hypofrontalität als Risikofaktor.  In: Baumann P (ed). Biologische Psychiatrie der Gegenwart. Wien, New-York: Springer. Pp: 385-389. 1992
62 Schreiber H., Westarp MP., Hülser PJ., Westphal KP., Wollinsky KH., Westarp ME., Mauch E., Laufen H., Kornhuber HH. Dokumentation von Zeichen chronischer Entzündungen und multifokaler Demyelinisierung des ZNS Motoneuronerkrankungen. Verh Dt Ges Neurol 7: 701 - 704. 1992
61 Schreiber H., Stolz-Born G., Rothmeier J., Kornhuber HH., Rothenberger A., Born J. Kinder schizophrener Eltern - Neurophysiologische Hinweise auf die Hypofrontalität als Risikofaktor.  Baumann P (ed). Biologische Psychiatrie der Gegenwart. Wien. New-York: Springer. pp: 385-389. 1992
60 Schreiber H., Kornhuber HH. Das Parkinson-Syndrom. Aktuelle Entwicklungen zur Pathogenese, Diagnostik und Therapie. Münch Med Wochenschr 134: 302.305. 1992
59 Kriebel, J., Kornhuber, A. and Scherb, W. Berblinger, Schneider von Ulm, Verfechter des Prinzips schwerer als Luft, Flieger und Orthopädiemechaniker - Ein Urahn der Flugmedizin ? In (Ed.), Jahrbuch 1991 der Dt. Ges. f. Luft- und Raumfahrt e.V., DGLR, 1991, pp. 629-633. 1991
58 Kriebel, J., Bitzer, C., Kornhuber, A., Besenthal, R. and Scherb, W. Aktuelle Medizinische Aspekte der Flugsicherheit In (Ed.), Jahrbuch I 1991 der Deutschen Gesellschaft f. Luft- und Raumfahrtmedizin e.V. (DGLR), DGLR, 1991, pp. 545-547. 1991
57 Rüb, K., Krapf, H., Kornhuber, A., Kornhuber, H.H. and Nagel, D. Schwer erkennbare chronische paranasale Sinusitiden als häufige Ursache von Kopfschmerzen In W. Firnhaber, K. Dworschak, K. Lauer, and M. Nichtweiss (Eds.), Verh Dt Gesell Neurol, Springer, Berlin, Heidelberg, 1991, pp. 527-528. 1991
56 Kornhuber, M.E., Balabanova, S., Heiligensetzer, G.V., Kornhuber, C.h., Zettlmeißl, H. and Kornhuber, A.W. Stability of human blood serum aminoacids after storage at different pH and temperature conditions Clinica Chimica Acta, 197 (1991) pp. 189-200. 1991
55 Kornhuber, H.H., Kornhuber, A., Kornhuber, J. and Backhaus, B. Vom "normalen" täglichen Alkohol zum Schlaganfall: Insulinresistenz, Hyperinsulinämie-Adipositas, Diabetes, Hypertonie, Hyperlipidämie  In W. Firnhaber, K. Dworschak, K. Lauer, and M. Nichtweiss (Eds.), Verh Dt Gesell Neurol, Springer, Berlin, Heidelberg, 1991, pp. 539-540. 1991
54 Bayer H., Frei-Kleiner S., Schreiber H. Schlafporbleme und nervöse Störungen. Da hilft die Passionsblume. Studie mit 1377 Patienten.  Ärztliche Praxis 43(21): 13-16. 1991
53 Schreiber H., Stolz-Born G., Rothmeier J., Kornhuber A., Kornhuber HH., Born J. Endogenous event-related brain potentials and psychometric performance in children at risk for schizophrenia. Biol Psychatry 30: 177-189. 1991
52 Kornhuber, A.W., Becker, W. and Jürgens, R. The Role of Visual Feedback and Preprogramming for Smooth Pursuit Eye Movements: Experiments with Velocity Steps In L. Deecke, J.C. Eccles, and V.B. Mountcastle (Eds.), From Neuron to Action, Springer-Verlag, Berlin, Heidelberg, 1990, pp. 175-178. 1990
51 Kornhuber, H.H., Backhaus, B., Kornhuber, A.W. and Kornhuber, J. Die Hauptursache von Diabetes (Typ II): der "normale" Alkoholkonsum Versicherungsmedizin, 42(5) (1990) pp. 132,134-142. 1990
50 Rothmeier J., Schreiber H., Fröscher W. Myositis ossificans circumscripta nach ungewöhnlichem "Hirtrauma". Fortschr. Med. 108 (21): 415-416. 1990
49 Kornhuber ME., Kornhuber HH., Kornhuber J., Schreiber H.., Westphal KP. Schizophrenia - autoimmune asthenia of the glutamate receptor? In: Stefanis CN et al (eds). Psychiatry: A world perspective - Volume 2. Elsevier, Amsterdam. Pp: 215-219. 1990
48 Schreiber H., Stolz-Born G., Kornhuber HH., Born J. Delayed endogenous evoked brain potentials in two independent groups of children at risk for schizophrenia. In:  Brunia CHM, AWK Gailard, A Kok (eds.). Psychophysiological Brain Research. Tilburg University Pres. Pp: 227-231. 1990
47 Schreiber H., Stolz-Born G., Rothmeier J., Kornhuber AW., Born J., Kornhuber HH. Evoked brain potentials and psychometric data in children at risk for schizophrenia. In: Deecke L, JC Eccles, VB Mountcastle (eds.). From Neuron to Action. An Appraisal of fundamental and clinical Research. Berlin: Springer. Pp:489-494. 1990
46 Schreiber H., Stolz-Born G., Rothmeier J., Kornhuber AW., Born J., Kornhuber HH. Evoked brain potentials and psychometric data in children at risk for schizophrenia. In: Deecke L. JC Eccles. VB mountcastle (eds.). From Neuron to Action. An Appraisal of fundamental and clinical Research. Berlin. Heidelberg. New.York: Springer. Pp: 489-494. 1990
45 Kornhuber, H.H., Backhaus, B., Kornhuber, A.W. and Kornhuber, J. Risk Factors and the Prevention of Stroke  In W.K. Amery, M.-.G. Bousser, and F.C. Rose (Eds.), Clinical Trial Methodology in Stroke, Bailliere Tindall, London, Philadelphia, 1989, pp. 191-212. 1989
44 Kornhuber, J., Kornhuber, H.H., Backhaus, B., Kornhuber, A., Kaiserauer, C. h. and Wanner, W. GGT-Normbereich bisher falsch definiert: Zur Diagnostik von Bluthochdruck, Adipositas und Diabetes infolge "normalen" Alkoholkonsums,  Versicherungsmedizin 41 (1989) pp. 78-81. 1989
43 Kornhuber, H.H., Kornhuber, J., Wanner, W., Kornhuber, A. and Kaiserauer, C. Alcohol, smoking and body build: obesity as a result of the toxic effect of 'social' alcohol consumption Clin. Physiol. Biochem., 7(3-4) (1989) pp. 203-216. 1989
42 Schreiber H., Stolz G., Rothenmeier J., Kornhuber HH., Born J. Prolonged latencies of the N2 and P3 of the auditory event-relatex potential in children at risk for schizophrenia. Eur Arch Psy Clin Neuro 238: 185-188. 1989
41 Jürgens, R., Kornhuber, A.W. and Becker, W. Prediction and Strategy in Human Smooth Pursuit Eye Movements In G. Lueer, U. Lass, and J. Shallo-Hoffmann (Eds.), Eye movement research: physiological and psychological aspects, Hogrefe, Göttingen, 1988, pp. 55-75. 1988
40 Widder, B., Kornhuber, H.H. and Kornhuber, A. Noninvasive ultrasound investigation of cerebral vessels in the case of vertigo and dizziness, Adv. Otorhinolaryngol., 41 (1988) pp. 231-234. 1988
39 Kornhuber, A.W., Jürgens, R. and Becker, W. Some Mechanisms in the Predictive Control of Smooth Pursuit Eye Movements Adv. Oto-Rhino-Laryng., 41 (1988) pp. 116-117. 1988
38 Kornhuber, A.W. INSTANT - Interaktive Statistik mit Protokollgenerator und BMDP-Präprozessor. Ein Vergleich mit BMDP und SAS In F. Faulbaum and H.-.M. Uehlinger (Eds.), Fortschritte der Statistik-Software 1., Gustav Fischer Verlag, Stuttgart, 1988. 1988
37 Kornhuber, J., Kornhuber, M.E., Hartmann, G.M. and Kornhuber, A.W. In Vivo Influences on Cerebrospinal Fluid Amino Acid Levels Neurochem. Int., 12(1) (1988) pp. 25-31. 1988
36 Kornhuber, J., Kornhuber, A.W., Kaiserauer, C.h. and Wanner, W.E. Guillain-Barre syndrome and serum activities of gamma-glutamyltransferase and glutamic-pyruvic transaminase Eur. Arch. Psychiatry Neurol. Sci., 237(6) (1988) pp. 317-319. 1988
35 Kaiserauer, C.h., Kornhuber, J., Kornhuber, A.W. and Bauer, K. Alcohol consumption, blood-cerebrospinal fluid barrier, and Guillain-Barre syndrome Pharmacopsychiatry, 21(6) (1988) pp. 310-311. 1988
34 Lang W., Lang M., Podreka I., Steiner M., Uhl F., Suess E., Müller C., Deecke L. DC-potential shifts and regional cerebral blood flow reveal frontal cortex involvement in human visuomotor learning. Exp Brain Res. 1988; 71(2): 353-64. 1988
33 Lang W., Lang M., Uhl F., Koska C., Kornhuber A., Deecke L. Negative cortical DC shifts preceding and accompanying simultaneous and sequential finger movements. Exp Brain Res. 1988;71(3): 579-87. 1988
32 Lang W., Lang M., Uhl F., Kornhuber A., Deecke L., Kornhuber HH. Left frontal lobe in verbal associative learning: a slow potential study. Exp Brain Res. 1988;70(1): 99-108. 1988
31 Lang W., Lang M., Kornhuber A., Diekmann V., Kornhuber HH. Event-related EEG-spectra in a concept formation task. Hum Neurobiol. 1988;6(4): 295-301. 1988
30 Uhl F., Lang W., Lang M, Kornhuber A, Deecke L. Cortical slow potentials in verbal and spatial tasks--the effect of material, visual hemifield and performing hand. Neuropsychologia. 1988; 26(5): 769-75. 1988
29 Kornhuber, A.W., Becker, W. and Jürgens, R. Is Constant Acceleration one Basic Element in Human Smooth Pursuit? In G. Luer and U. Lass (Eds.), Fourth European Conference on Eye Movements; Proceedings, C.J. Hogrefe, Inc., Toronto, Lewiston, G, 1987, pp. 136-138. 1987
28 Scheben, B., Henkler, C., Kornhuber, A., Kornhuber, H.H., Maier, V., Molz, K.H., Swobodnik, W. and Wechsler, J.G. On the Road to Stroke: Hepatic Steatosis and Hyperinsulinämia Associated with Normal Alcohol Use in Young Males In K. Poeck, W. Hacke, and R. Schneider (Eds.), Verh Dt Gesell Neurol, Springer, Berlin, Heidelberg, 1987, pp. 674-675. 1987
27 Kornhuber, J., Kaiserauer, C.H., Kornhuber, A.W. and Kornhuber, M.E. Alcohol consumption and blood-cerebrospinal fluid barrier dysfunction in man Neuroscience Letters, 79 (1987) pp. 218-222. 1987
26 Kornhuber, J., Kaiserauer, C.H. and Kornhuber, A.W. Alkoholkonsum und Blut-Liquor-Schranke Deutsche Medizinische Wochenschrift, 112 (1987) pp. 568-569 1987
25 Henkler, C., Scheben, B., Kornhuber, A., Kornhuber, H.H., Molz, K.H., Maier, V., Swobodnik, W. and Wechsler, J.G. Am Anfang des Weges zum Schlaganfall: Insulinrezeptorschaden und Fettleber-Hyperinsulinismus bei jungen Männern Dtsch. Med. Wochenschr., 112(4) (1987) pp. 157-158. 1987
24 Altmann, J., Kornhuber, A.W. and Kornhuber, H.H.,  Stroke: Cardiovascular Risk Factors and the Quantitative Effects of Dietary Treatment on Them European Neurology, 26 (1987) pp. 90-99 1987
23 Altmann, J., Kornhuber, A. and Kornhuber, H.H. Riskfactors "normal" alcohol consumption, oral antidiabetic drugs and treatment of stroke In K. Poeck, W. Hacke, and R. Schneider (Eds.), Verh Dt Gesell Neurol, Springer, Berlin, Heidelberg, 1987, pp. 672-673 1987
22 Lang W., Lang M., Goldenberg G., Podreka I., Deecke L. EEG and rCBF evidence for left frontocortical activation when memorizing verbal material. Electroencephalogr Clin Neurophysiol Suppl. 1987; 40: 328-34. 1987
21 Lang W., Lang M., Kornhuber A., Deecke L., Kornhuber HH. Slow negative potential shifts in conflicting response paradigms. Electroencephalogr Clin Neurophysiol Suppl. 1987; 40: 53-8. 1987
20 Lang M., Lang W., Uhl F., Kornhuber A. Slow negative potential shifts in a verbal concept formation task. Electroencephalogr Clin Neurophysiol Suppl. 1987; 40: 335-40. 1987
19 Lang M., Lang W., Diekmann V., Kornhuber HH. The frontal theta rhythm indicating motor and cognitive learning. Electroencephalogr Clin Neurophysiol Suppl. 1987; 40: 322-7. 1987
18 Deecke L., Uhl F., Spieth F., Lang W., Lang M. Cerebral potentials preceding and accompanying verbal and spatial tasks. Electroencephalogr Clin Neurophysiol Suppl. 1987. 40: 17-23. 1987
17 Lang M., Lang W., Uhl F., Kornhuber A., Deecke L., Kornhuber HH. Slow negative potential shifts indicating verbal cognitive learning in a concept formation task. Hum Neurobiol. 1987; 6(3): 183-90. 1987
16 Lang M., Lang W., Diekmann V., Kornhuber HH. The frontal theta rhythm indicating motor and cognitive learning. Electroencephalogr Clin Neurophysiol. Suppl. 1987; 40: 322-7. 1987
15 Scheben, B., Henkler, C., Kornhuber, A., Kornhuber, H.H., Maier, V., Molz, K.H., Swobodnik, W. and Wechsler, J.G. On the Road to Stroke: Hepatic Steatosis and Hyperinsulinaemia Associated with Normal Alcohol Use in Young Males Verh Dt Gesell Neurol, (1986) 1986
14 Kornhuber, M., Kornhuber, J., Kornhuber, A.W. and Hartmann, M. Positive Correlations between Contamination by Blood and Amino Acid Levels in Cerebrospinal Fluid of the Rat Neuroscience Letters, 69 (1986) pp. 212-215. 1986
13 Altmann, J., Kornhuber, A. and Kornhuber, H.H. Riskfactors "normal" alcohol consumption, oral antidiabetic drugs and treatment of stroke Verh Dt Gesell Neurol, (1986) 1986
12 Decke L., Kornhuber HH., Schreiber H., Lang M., Lang W., Kornhuber A., Heise B., Keidel M. Bereitschaftspotential associated with writing and drawing. In: McCallum WV, Zappoli R, Denoth F (eds). Cerebral psychophysiology: Studies in eventrelated potentials. EEG Suppl 38: 245-247. Elsevier, Amsterdam. 1986
11 Lang W., Lang M., Kornhuber A., Kornhuber HH. Electrophysiological evidence for right frontal lobe dominance in spatial visuomotor learning Arch Ital Biol. 1986 Feb; 124(1): 1-13. 1986
10 Hufnagl, J.M., Kornhuber, A., Kornhuber, H.H. and Krapf, H. Kopfschmerz unklarer Genese: Hirntumor? Zur Indikation der Computertomographie Deutsche Medizinische Wochenschrift, 110 (1985) pp. 1035-1038. 1985
9 Frank P., Maunz M., Rösch R., Schreiber H. Mediscript. Kommentierte Staatsexamsfragen zum 2. Abschnitt der ärztlichen Prüfung. Mediscript-Verlag. 1985
8 Deecke L., Kornhuber HH., Lang W., Lang M., Schreiber H. Timing function of the frontal cortex in sequential motor and learning tasks. Human Neurobiology 4: 143-154. 1985
7 Deecke L., Kornhuber HH., Lang W., Lang M., Schreiber H. Timing function of the frontal cortex in sequential motor and learning tasks. Hum Neurobiol. 1985; 4(3): 143-54. 1985
6 Lang W., Lang M., Kornhuber A., Gallwitz A., Kriebel J. Neuropsychological and neuroendocrinological disturbances associated with extracerebral cysts of the anterior and middle cranial fossa. Eur Arch Psychiatry Neurol Sci. 1985; 235(1): 38-41. 1985
5 Deecke L., Heise B., Kornhuber HH., Lang M., Lang W. Brain potentials associated with voluntary manual tracking: bereitschaftspotential, conditioned premotion positivity, directed attention potential, and relaxation potential. Anticipatory activity of the limbic and frontal cortex. Ann NY Acad Sci. 1984; 425:450-64. 1984
4 Lang W., Lang M., Heise B., Deecke L., Kornhuber HH. Brain potentials related to voluntary hand tracking, motivation and attention. Hum Neurobiol. 1984; 3(4): 235-40. 1984
3 Schreiber H., Lang M., Lang W., Kornhuber A., Heise B., Keidel M., Deecke L. Frontal hemispheric differences in the Bereitschaftspotential associated with writing and drawing. Human Neurobiol 2: 197 - 202. 1983
2 Schreiber H., Lang M., Lang W., Kornhuber A., Heise B., Keidel M., Deecke L., Kornhuber HH. Frontal hemispheric differences in the Bereitschaftspotential associated with writing and drawing. Hum Neurobiol. 1983; 2(3): 197-202. 1983
1 Lang W., Lang M., Kornhuber A., Deecke L., Kornhuber HH. Human cerebral potentials and visuomotor learning. Pflugers Arch. 1983 Dec; 399(4): 342-4. 1983




Umsetzung: artifox.com



Neurologie Ulm | Physioconcept Ulm | BEGUMED GmbH | M1 Physiotherapie Ulm
ulmmed | PatientConcept App | NeuroSys GmbH | Parkinson Youngster